Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Course of amoxicillin

Phase 3Small molecule

AAssistance Publique - Hôpitaux de Paris

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

ErysipelasNot yet recruiting

ErysipelasPhase 3

Not yet recruiting

Timeline

Expected Milestones

Q1 2029

Post-ApprovalNot yet recruiting

Erysipelas

NCT07104552

Clinical

Trials by Indication[1]

Erysipelas1 trial

Comparing Short to Standard Amoxicillin Course for Erysipelas

Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT07104552·656 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Course of amoxicillin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Course of amoxicillin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Course of amoxicillin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAssistance Publique - Hôpitaux de Paris

Related News